| Qualitative Assay | Application | LOD | Technique | Type Amplification |
| AmpliScreen 2.0 (Roche Molecular System) | Blood screening | < 50 UI/ml | Semi-automated rtPCR | Target |
| Amplicor HCV 2.0 (Roche Molecular System) | To Confirm active infection | 60 UI/ml in serum 50 UI/ml in EDTA | Manual rtPCR | Target |
| Cobas Amplicor Monitor HCV 2.0 (Roche Molecular System) | To Confirm active infection | 50 UI/ml in EDTA 60 UI/ml in serum | Semi-automated rtPCR | Target |
| Versant HCV RNA (Siemens Healthcare Diagnotics) | To Confirm active infection/ Blood screening | 5 IU/mll | Semi-automated TMA | Target |
| Procleix HIV/HCV assay (Gen Probe) | To Confirm active infection/ Blood screening | <50 IU/ml | Manual TMA | Target |
| Procleix Ultrio assay (Gen Probe) | To Confirm active infection/ Blood screening | <50 IU/ml | Automated TMA | Target |
| Quantitative Assay | LOD and Dynamic Range (IU/L) | 1 IU/L conversion | Technique | Type Amplification |
| Amplicor HCV Monitor 2.0 (Roche Molecular System) | 600 (600-500,000) | 0.9 copies/ml | Manual competitive rtPCR | Target |
| Cobas Amplicor Monitor HCV 2.0 (Roche Molecular System) | 600 (600-500,000) | 2.4 copies/ml | Semi-automated competitive rtPCR/ automated | Target |
| Cobas AmliPrep/Cobas TaqMan HCV (Roche Molecular System) | 15(43—69,000,000) | 2.7 copies/ml | Semi-automated compeitive rtPCR | Target |
| Versant HCV RNA 3.0 Quantitative assay (Siemens Health Care Diagnostics) | 520 (615-700,000) | 5.2 copies/ml | Semi-automated branched DNA Assay | Signal |
| LCx HCV RNA Quantitative assay (Abbott Laboratories) | 23 (25-2,300,000) | 4.3 copies/ml | Semi-automated Competitive rtPCR | Target |
| SuperQuant (National Genetic Institute) | 100 (600-1,470,000) | 3.4 copies/ml | Semi-automated Competitive rtPCR | Target |
| Abbott RealTime (Abbott Molecular Diagnostics) | 12 (12-100,000,000) | Not available | Automated rtPCR | Target |